Stockscreener 앱 받기
177.32
0.60%
-1.07
전일 마감가:
$178.39
열려 있는:
$177.2
하루 거래량:
432.92K
Relative Volume:
0.85
시가총액:
$5.26B
수익:
$755.59M
순이익/손실:
$33.05M
주가수익비율:
165.72
EPS:
1.07
순현금흐름:
$38.20M
1주 성능:
-4.47%
1개월 성능:
-4.20%
6개월 성능:
-5.34%
1년 성능:
-3.97%
1일 변동 폭
$173.38
$178.72
1주일 범위
$173.38
$185.37
52주 변동 폭
$123.00
$257.40
Inspire Medical Systems Inc Stock (INSP) Company Profile
명칭
Inspire Medical Systems Inc
전화
763-957-5037
주소
5500 WAYZATA BLVD, GOLDEN VALLEY
INSP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
177.32 | 5.26B | 755.59M | 33.05M | 38.20M | 1.07 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-05-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-04-19 | 개시 | RBC Capital Mkts | Outperform |
| 2024-03-19 | 개시 | Morgan Stanley | Overweight |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2024-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-12-13 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-11-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-11-03 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2020-09-22 | 개시 | JP Morgan | Overweight |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-08-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-07-15 | 개시 | Goldman | Buy |
| 2020-06-18 | 재확인 | Piper Sandler | Overweight |
| 2020-05-18 | 개시 | Lake Street | Buy |
| 2020-04-28 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | 개시 | Piper Sandler | Overweight |
| 2020-01-28 | 개시 | Oppenheimer | Underperform |
| 2020-01-27 | 개시 | Oppenheimer | Underperform |
| 2019-11-06 | 업그레이드 | Berenberg | Sell → Hold |
| 2019-02-05 | 개시 | Dougherty & Company | Buy |
| 2018-11-28 | 개시 | Berenberg | Sell |
| 2018-10-29 | 개시 | Leerink Partners | Outperform |
| 2018-05-29 | 개시 | Guggenheim | Buy |
| 2018-05-29 | 개시 | Stifel | Buy |
| 2018-05-29 | 개시 | Wells Fargo | Outperform |
모두보기
Inspire Medical Systems Inc 주식(INSP)의 최신 뉴스
INVESTOR ALERT: Levi & Korsinsky Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 20, 2024INSP - ACCESS Newswire
Levi & Korsinsky Notifies Inspire Medical Systems, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – INSP - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 20, 2024 – INSP - ACCESS Newswire
FINAL INSP DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Inspire Medical Systems, Inc. Investors of Last Few Hours to Join the Class Action Lawsuit! - ACCESS Newswire
Inspire Medical Systems: Will The Expansion of Inspira V Be A Game Changer? - Smartkarma
Inspire medical systems exec sells shares worth $4.69 million - Investing.com India
Inspire medical systems exec sells shares worth $4.69 million By Investing.com - Investing.com Nigeria
Inspire Medical Systems' SWOT analysis: stock poised for growth amid challenges - MSN
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical ... - The Bakersfield Californian
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder - GlobeNewswire
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts - MSN
Inspire medical systems CTO sells $99,395 in stock - MSN
FY2028 Earnings Forecast for INSP Issued By Leerink Partnrs - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat
John Rondoni Sells 583 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) Stock - MarketBeat
Wells Fargo & Company Issues Pessimistic Forecast for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat
Inspire Medical Systems (NYSE:INSP) Price Target Lowered to $248.00 at Robert W. Baird - MarketBeat
Leerink Partnrs Issues Positive Outlook for INSP Earnings - MarketBeat
Inspire medical systems CTO sells $99,395 in stock By Investing.com - Investing.com Australia
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat
WCM Investment Management LLC Takes $10.29 Million Position in Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat
Piper Sandler Cuts Inspire Medical Systems (NYSE:INSP) Price Target to $233.00 - MarketBeat
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88% - Nasdaq
Inspire Medical Systems, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Canada Finance
Truist Financial Has Lowered Expectations for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat
Inspire Medical's Earnings Surge in Q4 - MSN
Inspire Medical price target lowered to $235 from $250 at Truist - Yahoo Finance
Inspire Medical Systems targets $940M-$955M revenue in 2025 with Inspire V launch - MSN
Piper Sandler cuts Inspire Medical stock target to $233 - MSN
Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook - br.ADVFN.com
Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates - MSN
Inspire Medical discloses DOJ civil false claims investigation - Fierce Biotech
Inspire Medical reveals DOJ civil investigation - MedTech Dive
Truist cuts Inspire Medical stock target to $235, retains buy rating - MSN
Leerink lifts Inspire Medical stock target to $194, maintains rating - MSN
RBC maintains Outperform on Inspire Medical, $260 price target - MSN
Inspire Medical Systems (NYSE:INSP) Shares Gap Down on Analyst Downgrade - MarketBeat
Piper Sandler maintains overweight on Inspire Medical stock, $233 target - MSN
Morgan Stanley cuts Inspire Medical stock target to $220 - MSN
Truist Adjusts Price Target on Inspire Medical Systems to $235 From $250, Maintains Buy Rating - Marketscreener.com
Inspire V on Track for Full Launch in 2025 - Sleep Review
A Look At The Fair Value Of Inspire Medical Systems, Inc. (NYSE:INSP) - Yahoo Canada Finance
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2024 Earnings Call Transcript - Insider Monkey
Inspire Medical Systems: Balancing Strong Performance with Operational Challenges and Regulatory Risks - TipRanks
Inspire Medical Systems revenue grows 25% in Q4 2024 - Medical Buyer
Lecap Asset Management Ltd. Has $974,000 Stake in Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat
Janney Montgomery Scott LLC Buys 3,427 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat
Inspire Medical Systems Inc (INSP) Q4 2024 Earnings Call Highlig - GuruFocus.com
Inspire Medical Systems Inc (INSP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Inspire Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Inspire Medical Systems Inc (INSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.16%
0.10%
자본화:
|
볼륨(24시간):